Refinement of the Structure of the Ligand-occupied Cholecystokinin Receptor Using a Photolabile Amino-terminal Probe

Xi Qin Ding, Vesile Dolu, Elizabeth M. Hadac, Eileen L. Holicky, Delia I. Pinon, Terry P. Lybrand, Laurence J Miller

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Affinity labeling is a powerful tool to establish spatial approximations between photolabile residues within a ligand and its receptor. Here, we have utilized a cholecystokinin (CCK) analogue with a photolabile benzoyl-phenylalanine (Bpa) sited in position 24, adjacent to the pharmacophoric domain of this hormone (positions 27-33). This probe was a fully efficacious agonist that bound to the CCK receptor saturably and with high affinity (Ki = 8.9 ± 1.1 nM). It covalently labeled the CCK receptor either within the amino terminus (between Asn10 and Lys 37) or within the third extracellular loop (Glu345), as demonstrated by proteolytic peptide mapping, deglycosylation, micropurification, and Edman degradation sequencing. Truncation of the receptor to eliminate residues 1-30 had no detrimental effect on CCK binding, stimulated signaling, or affinity labeling through a residue within the pharmacophore (Bpa 29) but resulted in elimination of the covalent attachment of the Bpa24 probe to the receptor. Thus, the distal amino terminus of the CCK receptor resides above the docked ligand, compressing the portion of the peptide extending beyond its pharmacophore toward the receptor core. Exposure of wild type and truncated receptor constructs to extracellular trypsin damaged the truncated construct but not the wild type receptor, suggesting that this domain also may play a protective role. Use of these additional insights into molecular approximations provided key constraints for molecular modeling of the peptide-receptor complex, supporting the counterclockwise organization of the transmembrane helical domains.

Original languageEnglish (US)
Pages (from-to)4236-4244
Number of pages9
JournalJournal of Biological Chemistry
Volume276
Issue number6
DOIs
StatePublished - Feb 9 2001

Fingerprint

Cholecystokinin Receptors
Cholecystokinin
Ligands
Phenylalanine
Labeling
Peptides
Peptide Mapping
Molecular modeling
Peptide Receptors
Trypsin
Hormones
Degradation

ASJC Scopus subject areas

  • Biochemistry

Cite this

Refinement of the Structure of the Ligand-occupied Cholecystokinin Receptor Using a Photolabile Amino-terminal Probe. / Ding, Xi Qin; Dolu, Vesile; Hadac, Elizabeth M.; Holicky, Eileen L.; Pinon, Delia I.; Lybrand, Terry P.; Miller, Laurence J.

In: Journal of Biological Chemistry, Vol. 276, No. 6, 09.02.2001, p. 4236-4244.

Research output: Contribution to journalArticle

Ding, Xi Qin ; Dolu, Vesile ; Hadac, Elizabeth M. ; Holicky, Eileen L. ; Pinon, Delia I. ; Lybrand, Terry P. ; Miller, Laurence J. / Refinement of the Structure of the Ligand-occupied Cholecystokinin Receptor Using a Photolabile Amino-terminal Probe. In: Journal of Biological Chemistry. 2001 ; Vol. 276, No. 6. pp. 4236-4244.
@article{dfe0050646a34cebaae32ef21407dfd0,
title = "Refinement of the Structure of the Ligand-occupied Cholecystokinin Receptor Using a Photolabile Amino-terminal Probe",
abstract = "Affinity labeling is a powerful tool to establish spatial approximations between photolabile residues within a ligand and its receptor. Here, we have utilized a cholecystokinin (CCK) analogue with a photolabile benzoyl-phenylalanine (Bpa) sited in position 24, adjacent to the pharmacophoric domain of this hormone (positions 27-33). This probe was a fully efficacious agonist that bound to the CCK receptor saturably and with high affinity (Ki = 8.9 ± 1.1 nM). It covalently labeled the CCK receptor either within the amino terminus (between Asn10 and Lys 37) or within the third extracellular loop (Glu345), as demonstrated by proteolytic peptide mapping, deglycosylation, micropurification, and Edman degradation sequencing. Truncation of the receptor to eliminate residues 1-30 had no detrimental effect on CCK binding, stimulated signaling, or affinity labeling through a residue within the pharmacophore (Bpa 29) but resulted in elimination of the covalent attachment of the Bpa24 probe to the receptor. Thus, the distal amino terminus of the CCK receptor resides above the docked ligand, compressing the portion of the peptide extending beyond its pharmacophore toward the receptor core. Exposure of wild type and truncated receptor constructs to extracellular trypsin damaged the truncated construct but not the wild type receptor, suggesting that this domain also may play a protective role. Use of these additional insights into molecular approximations provided key constraints for molecular modeling of the peptide-receptor complex, supporting the counterclockwise organization of the transmembrane helical domains.",
author = "Ding, {Xi Qin} and Vesile Dolu and Hadac, {Elizabeth M.} and Holicky, {Eileen L.} and Pinon, {Delia I.} and Lybrand, {Terry P.} and Miller, {Laurence J}",
year = "2001",
month = "2",
day = "9",
doi = "10.1074/jbc.M003798200",
language = "English (US)",
volume = "276",
pages = "4236--4244",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "6",

}

TY - JOUR

T1 - Refinement of the Structure of the Ligand-occupied Cholecystokinin Receptor Using a Photolabile Amino-terminal Probe

AU - Ding, Xi Qin

AU - Dolu, Vesile

AU - Hadac, Elizabeth M.

AU - Holicky, Eileen L.

AU - Pinon, Delia I.

AU - Lybrand, Terry P.

AU - Miller, Laurence J

PY - 2001/2/9

Y1 - 2001/2/9

N2 - Affinity labeling is a powerful tool to establish spatial approximations between photolabile residues within a ligand and its receptor. Here, we have utilized a cholecystokinin (CCK) analogue with a photolabile benzoyl-phenylalanine (Bpa) sited in position 24, adjacent to the pharmacophoric domain of this hormone (positions 27-33). This probe was a fully efficacious agonist that bound to the CCK receptor saturably and with high affinity (Ki = 8.9 ± 1.1 nM). It covalently labeled the CCK receptor either within the amino terminus (between Asn10 and Lys 37) or within the third extracellular loop (Glu345), as demonstrated by proteolytic peptide mapping, deglycosylation, micropurification, and Edman degradation sequencing. Truncation of the receptor to eliminate residues 1-30 had no detrimental effect on CCK binding, stimulated signaling, or affinity labeling through a residue within the pharmacophore (Bpa 29) but resulted in elimination of the covalent attachment of the Bpa24 probe to the receptor. Thus, the distal amino terminus of the CCK receptor resides above the docked ligand, compressing the portion of the peptide extending beyond its pharmacophore toward the receptor core. Exposure of wild type and truncated receptor constructs to extracellular trypsin damaged the truncated construct but not the wild type receptor, suggesting that this domain also may play a protective role. Use of these additional insights into molecular approximations provided key constraints for molecular modeling of the peptide-receptor complex, supporting the counterclockwise organization of the transmembrane helical domains.

AB - Affinity labeling is a powerful tool to establish spatial approximations between photolabile residues within a ligand and its receptor. Here, we have utilized a cholecystokinin (CCK) analogue with a photolabile benzoyl-phenylalanine (Bpa) sited in position 24, adjacent to the pharmacophoric domain of this hormone (positions 27-33). This probe was a fully efficacious agonist that bound to the CCK receptor saturably and with high affinity (Ki = 8.9 ± 1.1 nM). It covalently labeled the CCK receptor either within the amino terminus (between Asn10 and Lys 37) or within the third extracellular loop (Glu345), as demonstrated by proteolytic peptide mapping, deglycosylation, micropurification, and Edman degradation sequencing. Truncation of the receptor to eliminate residues 1-30 had no detrimental effect on CCK binding, stimulated signaling, or affinity labeling through a residue within the pharmacophore (Bpa 29) but resulted in elimination of the covalent attachment of the Bpa24 probe to the receptor. Thus, the distal amino terminus of the CCK receptor resides above the docked ligand, compressing the portion of the peptide extending beyond its pharmacophore toward the receptor core. Exposure of wild type and truncated receptor constructs to extracellular trypsin damaged the truncated construct but not the wild type receptor, suggesting that this domain also may play a protective role. Use of these additional insights into molecular approximations provided key constraints for molecular modeling of the peptide-receptor complex, supporting the counterclockwise organization of the transmembrane helical domains.

UR - http://www.scopus.com/inward/record.url?scp=0035830920&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035830920&partnerID=8YFLogxK

U2 - 10.1074/jbc.M003798200

DO - 10.1074/jbc.M003798200

M3 - Article

C2 - 11050076

AN - SCOPUS:0035830920

VL - 276

SP - 4236

EP - 4244

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 6

ER -